111 related articles for article (PubMed ID: 14624348)
1. [Interdisciplinary oncologic after-care exemplified by second primary tumors after bladder carcinoma].
Klotz T; Hofstädter F; Gerken M
Urologe A; 2003 Nov; 42(11):1485-90. PubMed ID: 14624348
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
3. Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor.
Palou J; Rodríguez-Rubio F; Huguet J; Segarra J; Ribal MJ; Alcaraz A; Villavicencio H
J Urol; 2005 Sep; 174(3):859-61; discussion 861. PubMed ID: 16093970
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract.
Matsui Y; Utsunomiya N; Ichioka K; Ueda N; Yoshimura K; Terai A; Arai Y
Urology; 2005 Feb; 65(2):279-83. PubMed ID: 15708038
[TBL] [Abstract][Full Text] [Related]
5. Urological implications of concurrent bladder and lung cancer.
Vainrib M; Leibovitch I
Isr Med Assoc J; 2007 Oct; 9(10):732-5. PubMed ID: 17987763
[TBL] [Abstract][Full Text] [Related]
6. Nephrogenic adenoma of the bladder in renal transplant and non-renal transplant patients: a review of 22 cases.
Tse V; Khadra M; Eisinger D; Mitterdorfer A; Boulas J; Rogers J
Urology; 1997 Nov; 50(5):690-6. PubMed ID: 9372876
[TBL] [Abstract][Full Text] [Related]
7. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder.
Moutzouris G; Barbatis C; Plastiras D; Mertziotis N; Katsifotis C; Presvelos V; Theodorou C
Scand J Urol Nephrol; 1999 Feb; 33(1):27-30. PubMed ID: 10100360
[TBL] [Abstract][Full Text] [Related]
8. Exploration of risk factors predicting outcomes for primary T1 high-grade bladder cancer and validation of the Spanish Urological Club for Oncological Treatment scoring model: Long-term follow-up experience at a single institute.
Miyake M; Gotoh D; Shimada K; Tatsumi Y; Nakai Y; Anai S; Torimoto K; Aoki K; Tanaka N; Konishi N; Fujimoto K
Int J Urol; 2015 Jun; 22(6):541-7. PubMed ID: 25857336
[TBL] [Abstract][Full Text] [Related]
9. Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens.
Bruins HM; Djaladat H; Ahmadi H; Sherrod A; Cai J; Miranda G; Skinner EC; Daneshmand S
J Urol; 2013 Nov; 190(5):1704-9. PubMed ID: 23707451
[TBL] [Abstract][Full Text] [Related]
10. Familial papillary renal cell tumors and subsequent cancers: a nationwide epidemiological study from Sweden.
Czene K; Hemminki K
J Urol; 2003 Apr; 169(4):1271-5. PubMed ID: 12629341
[TBL] [Abstract][Full Text] [Related]
11. Synchronous primary cancers of urinary bladder and kidney and prostate.
Tiwari P; Tripathi A; Bansal P; Vijay M; Gupta A; Kundu AK
Saudi J Kidney Dis Transpl; 2012 Jul; 23(4):786-9. PubMed ID: 22805392
[TBL] [Abstract][Full Text] [Related]
12. [De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients].
di Capua Sacoto C; Luján Marco S; Bahilo Mateu P; Budía Alba A; Pontones Moreno JL; Jiménez Cruz JF
Actas Urol Esp; 2010 Jan; 34(1):88-94. PubMed ID: 20223138
[TBL] [Abstract][Full Text] [Related]
13. Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer.
Kurokawa K; Ito K; Yamamoto T; Takechi H; Miyamoto S; Suzuki K; Yamanaka H
Urology; 2004 Feb; 63(2):268-72. PubMed ID: 14972469
[TBL] [Abstract][Full Text] [Related]
14. Multiple primary cancers (MPC) associated with bladder cancer: an analysis of the clinical and autopsy cases in Japan.
Kotake T; Kiyohara H
Jpn J Clin Oncol; 1985 Apr; 15 Suppl 1():201-10. PubMed ID: 4009982
[TBL] [Abstract][Full Text] [Related]
15. Follow-up after cystectomy for carcinoma of the bladder.
Montie JE
Urol Clin North Am; 1994 Nov; 21(4):639-43. PubMed ID: 7974895
[TBL] [Abstract][Full Text] [Related]
16. Presence of Concomitant Non-muscle-invasive Bladder Cancer in Chinese Patients with Upper Tract Urothelial Carcinoma: Risk Factors, Characteristics, and Predictive Value.
Fang D; Zhang L; Li X; Yu W; Singla N; Zhao G; Xiong G; Song Y; He Q; He Z; Zhou L
Ann Surg Oncol; 2015 Aug; 22(8):2789-98. PubMed ID: 25564161
[TBL] [Abstract][Full Text] [Related]
17. Surveillance, initial assessment, and subsequent progress of patients with superficial bladder cancer in a prospective longitudinal study. National Bladder Cancer Collaborative Group A (NBCCGA).
Cancer Res; 1977 Aug; 37(8 Pt 2):2907-10. PubMed ID: 872120
[TBL] [Abstract][Full Text] [Related]
18. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
19. Impact of tumour grade, stage, number and size, smoking habits and sex on the recurrence rate and disease-free interval in patients with transitional cell carcinoma of the bladder.
Raitanen MP; Tammela TL
Ann Chir Gynaecol; 1995; 84(1):37-41. PubMed ID: 7645909
[TBL] [Abstract][Full Text] [Related]
20. Expectant management of small, recurrent, noninvasive papillary bladder tumors.
Soloway MS; Bruck DS; Kim SS
J Urol; 2003 Aug; 170(2 Pt 1):438-41. PubMed ID: 12853794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]